Sorafenib Tosylate 200 mg/1

Sorafenib Tosylate 200 mg is an oral medication used to treat certain types of cancer. This film-coated tablet is manufactured by Mylan Pharmaceuticals Inc. in the USA.

Sorafenib Tosylate is primarily used in the treatment of advanced renal cell carcinoma and unresectable hepatocellular carcinoma. It works by inhibiting the growth of cancer cells. Patients often wonder, 'What is Sorafenib used for?' and it is typically prescribed for these specific cancer types.

Common effects of Sorafenib Tosylate may include fatigue, weight loss, and hand-foot skin reaction. Some users also experience diarrhea or nausea. These effects can vary from person to person.

Sorafenib Tosylate should be handled with care. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication. Store the tablets in a cool, dry place away from direct sunlight.

Sorafenib Tosylate may interact with certain medications, including those metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.